Eden Research PLC (LON:EDEN) has said its nematicide biopesticide formulation, which is marketed as Cedroz by its commercial partner, Eastman Chemical Company has received EU product authorisation from the Regulatory Affairs Directorate in Malta. The AIM-listed company noted that, following the authorisation by Malta, the concerned Member States must grant their individual approvals for the sale and use of Cedroz within their jurisdictions. Eden's CEO Sean Smith tells Proactive London how the company is now chasing approvals in other territories. He added that the pending approvals will cover Spain and Italy, for outdoor uses and will also cover France, Belgium, the Netherlands and the United Kingdom, as well as Spain and Italy, for professional greenhouse uses. Cedroz is designed to fight nematodes, a species that is known to cause severe damage to crops globally for both open field and greenhouse growers, resulting in yield losses and increasing farmers costs. Malta has authorised the use of Cedroz on a wide range of crops, including cucumbers, courgettes, melons, aubergine, peppers, tomatoes and strawberries. Once approved, the company added, Cedroz will be the first of Eden Research's formulations to be sold and used in the United Kingdom, where the firm is headquartered.
Eden Research partner gets EU product authorisation from Malta for biopesticide Cedroz
Quick facts: Eden Research plc
Price: 7.75 GBX
Market Cap: £16.06 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Eden Research plc named herein, including the promotion by the Company of Eden Research plc in any Content on the Site, the Company receives...FOR OUR FULL DISCLAIMER CLICK HERE